25. Right Heart Catheterization & Pulmonary Hemodynamics in the ICU

Quick Recap

Respiratory System, new protocol. Companion to Vasopressor & Inotrope Selection & Titration and Fluid Responsiveness & Hemodynamic Assessment (Cardiovascular System) — addresses the specific tool (pulmonary artery catheter/right heart catheterization) underlying invasive hemodynamic assessment, including a genuinely fascinating history of falling out of favor, then partially swinging back.

1. Definition

Right heart catheterization (RHC), performed via a pulmonary artery catheter (PAC/Swan-Ganz catheter), measures right atrial, right ventricular, and pulmonary artery pressures, pulmonary artery wedge pressure (PAWP, a surrogate for left atrial pressure), and cardiac output — remains an important diagnostic tool for pulmonary hypertension, shock, valvular heart disease, and unexplained dyspnea. The hemodynamic gold-standard definition of cardiogenic shock specifically requires cardiac index <2.2 L/min/m² and PAWP >15mmHg — a diagnosis genuinely dependent on invasive measurement, not achievable by clinical impression alone given the historically poor correlation between clinical evaluation and true hemodynamic status in acute shock.

2. A Genuinely Dramatic History — From Ubiquitous to Nearly Abandoned to Partial Revival

The SUPPORT study (Connors et al., JAMA 1996), a large prospective cohort study of RHC in critically ill ICU patients, found RHC use was associated with WORSE outcomes — a landmark, field-changing finding that drove a dramatic, sustained decline in PAC use across critical care over the following decade. This protocol treats the SUPPORT finding as genuinely important historical context, not a dismissible anomaly — it fundamentally reshaped how invasive hemodynamic monitoring is used.

However, PAC use has genuinely increased again in recent years, specifically for guiding management decisions in cardiogenic shock — driven by newer observational data suggesting a more nuanced picture than SUPPORT's blanket finding.

3. Current Evidence in Cardiogenic Shock — Genuinely Conflicting Meta-Analyses

This is a genuine area of live disagreement in the literature, not a settled question:

• One systematic review/meta-analysis (Lee et al., J Thorac Dis 2023) found PAC monitoring was NOT associated with lower in-hospital mortality overall in cardiogenic shock — but found a cause-specific signal: PAC monitoring may be beneficial specifically in cardiogenic shock caused by acute decompensated heart failure, but NOT in cardiogenic shock caused by acute coronary syndrome — a genuinely important, easily-overlooked distinction; the etiology of the shock, not just its presence, may determine whether invasive monitoring actually helps
• A separate systematic review/meta-analysis of observational studies, pooling results adjusted for confounders, found the PAC group WAS associated with lower short-term mortality — directly in tension with the Lee et al. finding above, despite both examining substantially the same clinical question
• Garan et al., JACC Heart Failure 2020: complete hemodynamic profiling with PAC in cardiogenic shock was associated with lower in-hospital mortality — another observational signal favoring PAC use
• A critical, easily-missed methodological point: the landmark ESCAPE trial (which found no benefit from PAC-guided therapy in heart failure) specifically EXCLUDED cardiogenic shock patients — meaning the general heart-failure PAC evidence base doesn't actually answer the cardiogenic-shock-specific question this protocol addresses, and shouldn't be extrapolated to that population
• Confounding by indication is a genuine, difficult-to-fully-resolve issue in all of this observational data: PAC patients consistently have more severe shock, worse hemodynamics, and higher rates of temporary mechanical circulatory support use than non-PAC patients — meaning any observed mortality difference (in either direction) is confounded by the fact that sicker patients are more likely to receive a PAC in the first place, not a clean randomized comparison

Practical synthesis of this genuinely unsettled picture: this protocol does not claim PAC use definitively improves or fails to improve cardiogenic shock outcomes overall — the honest state of evidence is a conflicting mix of observational signals, confounded by indication, with a plausible but unconfirmed cause-specific distinction (ADHF vs. AMI-related shock) that deserves more attention than a single "does PAC help in CS" framing allows. High-quality randomized trials are explicitly still needed per the current review literature.

4. Modern Refinements

Third-generation PAC devices now incorporate integrated pulse wave analysis and automated (continuous) thermodilution, improving measurement accuracy and reducing the operator-dependent variability of earlier-generation devices. Combining PAC data with echocardiographic findings provides a more holistic hemodynamic assessment than either modality alone — not an either/or choice, but complementary information sources, particularly relevant in the ICU setting where bedside echo is already widely used (cross-reference the POCUS content embedded throughout this library's shock-related protocols).

5. Modern Recommended Use — Targeted, Not Universal

Current guidance supports selective, not routine, PAC use: high-risk cardiovascular profiles, hemodynamic instability, or refractory shock — with cardiogenic shock staging systems (e.g., SCAI stages) helping identify which specific patients are most likely to benefit from the additional invasive data. This is a genuinely different practice pattern from the pre-SUPPORT era of near-universal PAC placement in any hemodynamically complex ICU patient.

6. Complications

RHC/PAC placement carries real procedural risk: bleeding, infection, and, rarely, cardiac or vascular injury — standardizing insertion protocols and clinician training is an active initiative aimed at reducing complications and improving data interpretation reliability, given that misinterpreted PAC data can be actively misleading rather than merely unhelpful.

7. Practical Synthesis

• Reserve PAC/RHC for genuinely high-acuity, diagnostically uncertain, or refractory shock cases rather than routine use in every hemodynamically complex ICU patient
• Consider the specific etiology of cardiogenic shock (ADHF vs. AMI-related) when weighing whether invasive monitoring is likely to change management — the evidence suggests these may not be equivalent
• Combine PAC data with echocardiography rather than relying on either alone
• Interpret any observational PAC-outcome data with real caution given confounding by indication — don't take an observed association (in either direction) as proof of a causal treatment effect
• Ensure adequately trained personnel place and interpret the catheter, given real procedural risk and the potential for misinterpreted data to actively mislead management

8. Consultation Matrix

9. Documentation & Medicolegal Checklist

• Indication for PAC placement documented (specific diagnostic uncertainty or refractory shock, not routine monitoring)
• Hemodynamic values and their influence on management decisions documented

10. Key Guidelines

• American Heart Association 2017 scientific statement on contemporary management of cardiogenic shock discusses PAC's role; no single guideline mandates universal or prohibits selective PAC use, reflecting the genuinely unsettled comparative evidence

11. Landmark Evidence

12. Controversies

• This protocol's central, honestly-acknowledged position is that current meta-analyses on PAC use in cardiogenic shock genuinely conflict with each other — not a matter of one being clearly higher quality than the other, but a real, unresolved area where confounding by indication makes the observational evidence base difficult to interpret cleanly in either direction.
• The possible ADHF-vs-AMI cause-specific distinction is a plausible, underexplored hypothesis rather than a well-established clinical rule — worth considering when deciding whether to place a PAC, but not yet validated enough to serve as a firm decision rule.
• High-quality RCT evidence specifically for PAC-guided management in cardiogenic shock remains genuinely absent — this protocol treats this as a real, acknowledged gap the field itself is calling for, not a settled matter awaiting only wider clinical adoption.

13. References

1. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276(11):889-897.
2. Lee J, Lee JB, Kim AR, Hyun J, Lee SE, Kim MS. Effectiveness of pulmonary artery catheter monitoring for patients with cardiogenic shock of various causes: a systematic review and meta-analysis. J Thorac Dis. 2023;15(3):1115-1123.
3. Garan AR, Kanwar M, Thayer KL, et al. Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC Heart Fail. 2020;8:903-913.
4. Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: a systematic review and meta-analysis of observational studies. J Card Fail. 2023.
5. The uses of right heart catheterization in cardio-pulmonary disease: State-of-the-art. 2025.
6. The pulmonary artery catheter in modern anesthesiology and intensive care: indications, benefits, and limitations. 2025.
7. Pulmonary Artery Catheter Utilization in Cardiogenic Shock: Clinical Characteristics and Outcomes. Circulation. 2024 (AHA Scientific Sessions abstract).
8. Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock.

See also: Vasopressor & Inotrope Selection & Titration and Fluid Responsiveness & Hemodynamic Assessment (Cardiovascular System) for the broader hemodynamic management framework this monitoring tool feeds into; Cardiogenic Shock (Cardiovascular System) for the clinical syndrome; Mechanical Circulatory Support Selection in Cardiogenic Shock (Cardiovascular System) and Post-Cardiotomy Mechanical Circulatory Support (Cardiac Surgery Critical Care) for the escalation pathway PAC data often informs.